IRONWOOD PHARMACEUTICALS, INC. Accounts Payable, Related Parties, Current
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Accounts Payable, Related Parties, Current of $400.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayableRelatedPartiesCurrent · last filed 2021-02-17
- 2020-09-30: Accounts Payable, Related Parties, Current $400.00K.
- 2020-06-30: Accounts Payable, Related Parties, Current $751.00K.
- 2020-03-31: Accounts Payable, Related Parties, Current $1.06M.
- 2019-12-31: Accounts Payable, Related Parties, Current $1.51M.
| Period end | Accounts Payable, Related Parties, Current |
|---|---|
| 2020-09-30 | $400.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $751.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.06M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $1.51M 10-K · filed 2021-02-17 |
| 2019-09-30 | $1.59M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $2.04M 10-Q · filed 2019-07-30 |
| 2016-12-31 | $1.00K 10-K · filed 2018-02-22 |
| 2015-12-31 | $3.00K 10-K · filed 2017-02-22 |
| 2014-12-31 | $8.00K 10-K · filed 2016-02-19 |
| 2014-09-30 | $6.00K 10-Q · filed 2014-11-05 |
| 2014-06-30 | $5.00K 10-Q · filed 2014-08-05 |
| 2014-03-31 | $18.00K 10-Q · filed 2014-04-29 |
| 2013-12-31 | $48.00K 10-K · filed 2015-02-18 |
| 2013-09-30 | $5.79M 10-Q · filed 2013-10-28 |
| 2013-06-30 | $7.27M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $26.44M 10-Q · filed 2013-04-23 |
| 2012-12-31 | $7.51M 10-K · filed 2014-02-07 |
| 2012-09-30 | $2.14M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $3.71M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $1.18M 10-Q · filed 2012-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |